Treatment of this condition with IL-17 blockade has been shown to:
A) Increase the risk of Reversible Posterior Leukoencephalopathy Syndrome
B) Worsen pre-existing multiple sclerosis
C) increase risk for mucosal candidal infections
D) Cause hepatic fibrosis with long term use
To find out the correct answer and read the explanation click here.
Please follow and like us: